Massachusetts General Hospital, Brigham and Women's Hospital, And Broad Institute Study Finds Targetable Mutation In Rare Brain Tumor

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A team led by investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH) and the Broad Institute has found that a gene mutation associated with several types of cancer also may be responsible for a rare but debilitating brain tumor called papillary craniopharyngioma. Their discovery, reported online in Nature Genetics, could lead to new therapies for this currently hard-to-treat tumor.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news